$Participation of the C-terminal propeptide procollagen type I in the formation of cardiofibrosis in patients with myocardial infarction with preserved left ventricular ejection fraction$

Participation of the C-terminal propeptide procollagen type I in the formation of cardiofibrosis in patients with myocardial infarction with preserved left ventricular ejection fraction

Aim. To study the dynamics of procollagen type I carboxy-terminal propeptide (PICP) with an assessment of potential associations with cardiac fibrosis (CF) and diastolic dysfunction (DD) of the left ventricle (LV) during the hospitalization and one year after ST segment elevation myocardial infarcti...

Full description

Bibliographic Details
Main Authors:	A. V. Osokina, V. N. Karetnikova, O. M. Polikutina, A. V. Ivanova, T. B. Pecherina, O. V. Gruzdeva, Yu. A. Dyleva, A. N. Kokov, N. K. Brel, O. L. Barbarash
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2021-03-01
Series:	Российский кардиологический журнал
Subjects:	myocardial infarction diastolic dysfunction chronic heart failure cardiofibrosis serum markers of fibrosis
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/4137

Similar Items

In-hospital changes of echocardiographic parameters and their relationship with the procollagen I C-terminal propeptide in patients with myocardial infarction and preserved left ventricle systolic function
by: A. V. Osokina, et al.
Published: (2020-03-01)

N-terminal propeptide of type III procollagen for predicting diastolic dysfunction in patients with myocardial infarction and preserved ejection fraction
by: A. V. Osokina, et al.
Published: (2021-02-01)

Fibrosis biomarkers and global myocardial strain in the diagnosis and prediction of diastolic dysfunction in patients with myocardial infarction and preserved ejection fraction
by: A. V. Osokina, et al.
Published: (2021-07-01)

Clinical significance and dynamics of biomarkers of myocardial remodeling in patients with ST segment elevation myocardial infarction and preserved left ventricular function
by: T. B. Pecherina, et al.
Published: (2018-03-01)

Serum level of N-terminal propeptide of type I procollagen in people of various ages and gender
by: V.V. Povoroznyuk, et al.
Published: (2020-02-01)

N-TERMINAL BRAIN NATRIURETIC PROPEPTIDE AS A MARKER OF MULTIFOCAL ATHEROSCLEROSIS IN PATIENTS WITH ST SEGMENT ELEVATION MYOCARDIAL INFARCTION
by: O. L. Barbarash, et al.
Published: (2012-06-01)

Galectin-3, N-terminal Propeptides of Type I and III Procollagen in Patients with Atrial Fibrillation and Metabolic Syndrome
by: Valery A. Ionin, et al.
Published: (2020-08-01)

BRAIN NATRIURETIC PROPEPTIDE AS A MARKER OF THE HEART DAMAGE IN METABOLIC SYNDROME
by: R. A. Libis, et al.
Published: (2015-04-01)

Relation of Procollagen Type III Amino Terminal Propeptide Level to Sepsis Severity in Pediatrics
by: Nagwan Y. Saleh, et al.
Published: (2021-09-01)

Quantitative analysis of serum procollagen type I C-terminal propeptide by immunoassay on microchip.
by: Shouki Yatsushiro, et al.
Published: (2011-01-01)

Profibrotic genetic polymorphisms as possible risk factors for the development of diastolic dysfunction in patients with epicardial adiposity
by: O. V. Gritsenko, et al.
Published: (2022-11-01)

QUANTIFICATION OF ECTOPIC FAT DEPOTS IN PATIENTS WITH CORONARY HEART DISEASE
by: A. N. Kokov, et al.
Published: (2019-09-01)

The utility of procollagen type 1 N-terminal propeptide for the bone status assessment in postmenopausal women
by: Elma Kučukalić-Selimović, et al.
Published: (2013-11-01)

RELATIONSHIP OF OBESITY PARAMETERS AND ADIPOKINES WITH THE RISK OF 2ND TYPE DIABETES DEVELOPMENT IN A YEAR AFTER MYOCARDIAL INFARCTION
by: O. V. Gruzdeva, et al.
Published: (2015-04-01)

Predictors of myocardial fibrosis and loss of epicardial adipose tissue volume in the long-term period after myocardial infarction
by: O. L. Barbarash, et al.
Published: (2020-03-01)

Cartilage type IIB procollagen NH2-propeptide, PIIBNP, inhibits angiogenesis
by: Zhepeng Wang, et al.
Published: (2021-12-01)

Predicting the risk of left ventricular diastolic dysfunction in obesity
by: G. A. Chumakova, et al.
Published: (2022-05-01)

Relationship between epicardial and perivascular fatty tissue and adipokine-cytokine level in coronary artery disease patients.
by: Olga Gruzdeva, et al.
Published: (2019-01-01)

Intra-Individual Changes in Total Procollagen-Type 1 N-terminal Propeptide in a Korean Adult Population
by: Rihwa Choi, et al.
Published: (2022-10-01)

Visceral adiposity index in patients with coronary artery disease, obesity and type 2 diabetes
by: A. A. Khorlampenko, et al.
Published: (2020-07-01)

The marker of adverse prognosis 1.5-anhydroglucitol in patients with coronary heart disease in the long-term period after planned myocardial revascularization
by: Yu S Ignatova, et al.
Published: (2019-04-01)

Effect of different doses of statins on the development of type 2 diabetes mellitus in patients with myocardial infarction
by: Gruzdeva O, et al.
Published: (2017-12-01)

Left atrial strain in assessing heart failure with preserved ejection fraction in hypertensive patients
by: E. S. Mazur, et al.
Published: (2022-09-01)

Procollagen type 1 N-terminal propeptide is associated with adverse outcome in acute chest pain of suspected coronary origin
by: Thomas Andersen, et al.
Published: (2023-09-01)

Serum and Echocardiographic Markers May Synergistically Predict Adverse Cardiac Remodeling after ST-Segment Elevation Myocardial Infarction in Patients with Preserved Ejection Fraction
by: Tamara Pecherina, et al.
Published: (2020-05-01)

CYTOKINE PROFILE IN VISCERAL OBESITY AND ADVERSE CARDIOVASCULAR PROGNOSIS OF MYOCARDIAL INFARCTION
by: O. V. Gruzdeva, et al.
Published: (2015-06-01)

Prognostic values of the diastolic index as a marker of chronic heart failure with preserved left ventricular ejection fraction
by: V. V. Syvolap, et al.
Published: (2024-02-01)

Cell Therapy for Heart Failure With Preserved Ejection Fraction∗
by: Barry A. Borlaug, MD, et al.
Published: (2016-01-01)

Perbedaan kadar carboxy terminal propeptide procollagen tipe I (PIP) serum pada pasien gagal jantung akibat hipertensi
by: AINI, Nurul
Published: (2010)

PERBEDAAN KADAR CARBOXY TERMINAL PROPEPTIDE PROCOLLAGEN TIPE I (PIP) SERUM PADA PASIEN GAGAL JANTUNG AKIBAT HIPERTENSI
by: , Nurul Aini, et al.
Published: (2012)

Relationship of visceral obesity and coronary calcinosis in ischemic heart disease
by: Natalia K. Brel, et al.
Published: (2021-12-01)

The role of cardiac magnetic resonance imaging in the assessment of heart failure with preserved ejection fraction
by: Clement Lau, et al.
Published: (2022-07-01)

Fragmented QRS and serum propeptide of type I procollagen in hypertensive patients: Putting another brick in the wall
by: Tolga Sinan Güvenç
Published: (2016-10-01)

Soluble ST2 in Heart Failure With Preserved Ejection Fraction
by: Omar F. AbouEzzeddine, et al.
Published: (2017-02-01)

Levels of C-terminal propeptide of type I procollagen and oxyproline in patients with systemic lupus erythematosus: The relationship between the course of the disease and the structural and functional state of bone tissue
by: S V. Shevchuk, et al.
Published: (2017-03-01)

Serum hyaluronic acid and procollagen III, N-terminal propeptide levels are highly associated with disease severity and predict the progression of COVID-19
by: Ti Yang, et al.
Published: (2023-10-01)

Correlation Between Serum Procollagen Type 1 N-Terminal Propeptide Level With Modified Rodnan Skin Score In Systemic Sclerosis Patients.
by: Vincent Vincent, et al.
Published: (2017-12-01)

Renal shear wave elastography and urinary procollagen type III amino-terminal propeptide (uPIIINP) in feline chronic kidney disease
by: Chutimon Thanaboonnipat, et al.
Published: (2019-02-01)

Heart failure with preserved ejection fraction: the role of diastolic stress test in diagnostic algorithms
by: E. N. Pavlyukova, et al.
Published: (2021-03-01)

Relationships between epicardial adipose tissue thickness and adipo-fibrokine indicator profiles post-myocardial infarction
by: Olga Gruzdeva, et al.
Published: (2018-03-01)